Mina Tahavvori
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mina Tahavvori has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Ali Adili
Department of Oncology, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications - Faroogh Marofi
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications - Gulinnaz Ercan
Department of Medical Biochemistry, Faculty of Medicine, Ege University, İzmir, Turkey
2 shared publications - Heshu Sulaiman Rahman
Branch of Basic Medical Sciences, College of Medicine, University of Sulaimani, Sulaimaniyah, Iraq
2 shared publications - Hossein Saeedi
Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications - Lakshmi Thangavelu
Center for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai-600077, India
2 shared publications
Latest Publications
- Open Access
- 15 June 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1
Correction to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
- 15 June 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1
Open AccessCorrection to: A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
- Open Access
- 2 June 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1-10
A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
Coronavirus disease (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The infection was reported in Wuhan, China, in late December 2019 and has become a major global concern due to severe respiratory infections and high transmission rates. Evidence suggests that the strong interaction between SARS-CoV-2 and patients' immune systems leads to various clinical symptoms of COVID-19. Although the adaptive immune responses are essential for eliminating SARS-CoV-2, the innate immune system may, in some cases, cause the infection to progress. The cytotoxic CD8+ T cells in adaptive immune responses demonstrated functional exhaustion through upregulation of exhaustion markers. In this regard, humoral immune responses play an essential role in combat SARS-CoV-2 because SARS-CoV-2 restricts antigen presentation through downregulation of MHC class I and II molecules that lead to the inhibition of T cell-mediated immune response responses. This review summarizes the exact pathogenesis of SARS-CoV-2 and the alteration of the immune response during SARS-CoV-2 infection. In addition, we’ve explained the exhaustion of the immune system during SARS-CoV-2 and the potential immunomodulation approach to overcome this phenomenon.
- 2 June 2022
- Published by Springer Nature in Cell Communication and Signaling
- Vol. 20 (1) , 1-10
Open AccessA comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
Coronavirus disease (COVID-19) is a viral infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. The infection was reported in Wuhan, China, in late December 2019 and has become a major global concern due to severe respiratory infections and high transmission rates. Evidence suggests that the strong interaction between SARS-CoV-2 and patients' immune systems leads to various clinical symptoms of COVID-19. Although the adaptive immune responses are essential for eliminating SARS-CoV-2, the innate immune system may, in some cases, cause the infection to progress. The cytotoxic CD8+ T cells in adaptive immune responses demonstrated functional exhaustion through upregulation of exhaustion markers. In this regard, humoral immune responses play an essential role in combat SARS-CoV-2 because SARS-CoV-2 restricts antigen presentation through downregulation of MHC class I and II molecules that lead to the inhibition of T cell-mediated immune response responses. This review summarizes the exact pathogenesis of SARS-CoV-2 and the alteration of the immune response during SARS-CoV-2 infection. In addition, we’ve explained the exhaustion of the immune system during SARS-CoV-2 and the potential immunomodulation approach to overcome this phenomenon.